Fig. 1From: Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trialLS mean change from baseline in EORTC QLQ-C30. a – GHS. b – Physical functioning. c – Pain. d – Fatigue up to 36 months (ITT population)Back to article page